For the quarter ending 2026-03-31, CORT made $164,903K in revenue. -$31,761K in net income. Net profit margin of -19.26%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Product revenue, net | 164,903 | 202,125 | 207,638 | 194,430 |
| Cost of sales | 2,883 | 2,545 | 4,596 | 3,433 |
| Research and development | 66,265 | 64,856 | 68,846 | 60,471 |
| Selling, general and administrative | 145,356 | 130,237 | 123,977 | 103,851 |
| Total operating expenses | 214,504 | 197,638 | 197,419 | 167,755 |
| (loss) income from operations | -49,601 | 4,487 | 10,219 | 26,675 |
| Interest and other income | 4,886 | 5,423 | 5,024 | 5,017 |
| (loss) income before income taxes | -44,715 | 9,910 | 15,243 | 31,692 |
| Income tax benefit | -12,954 | -14,378 | -4,425 | -3,457 |
| Net (loss) income | -31,761 | 24,288 | 19,668 | 35,149 |
| Basic EPS | -0.3 | 0.234 | 0.19 | 0.33 |
| Diluted EPS | -0.3 | 0.202 | 0.16 | 0.29 |
| Basic Average Shares | 104,435,000 | 103,686,000 | 103,545,000 | 104,111,000 |
| Diluted Average Shares | 104,435,000 | 120,205,000 | 119,439,000 | 120,485,000 |
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)